GFAP and major depressive disorder: For instance, individuals with MDD and bipolar disorder (BD) exhibited a reduction in S100B+ astrocyte abundance, while those with schizophrenia and MDD showed a decline in the abundance of astrocytes expressing phosphorylated GFAP, a feature that is absent in BD [27,28].